Oxford Biomedica (otc) (GB:OXB) has released an update.
Oxford Biomedica, a leader in cell and gene therapy, has announced its Annual General Meeting (AGM) scheduled for June 24, 2024. Shareholders are being updated with the 2023 Annual report and accounts, available on the company’s website. The AGM will take place at the company’s headquarters in Oxford, marking another step in its mission to deliver transformative therapies worldwide.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
